Community
/
Blog
/
Article
Blog Article

Outsourced vs DIY Regulatory services: Perspectives

Addressing product development and regulatory hurdles, medical device and IVD manufacturers are advised to assess capabilities and seek external expertise for market success.

Written by:
Published on:
April 30, 2024

Outsourced vs. DIY Regulatory Services

As the saying goes, time is money. A medical device or invitro diagnostic (IVD) manufacturer, whether a start-up or an established multi-national firm, must carefully balance the time its new or ongoing product development is taking against available resources. The more time – and effort – it takes to get a new product to market, or keep an existing one on the market, the greater the risk that allocated resources will dry up. And, as a result, a planned new product won’t even make it onto the market or an existing one won’t be able to stay on the market. This will prevent the products’ manufacturer from being able to recoup and expand on its initial or ongoing investments. And most importantly, if this happens, the products won’t be able to achieve their intended clinical benefits.

Regulatory challenges like meeting the Medical Device Regulations (MDR) and Invitro Diagnostic Device Regulations (IVDR) in the European Union and heightened cybersecurity scrutiny from regulators around the world makes it particularly difficult to meet market launch and recertification timelines. Pure Global has been hearing from its medical device and IVD manufacturer clients that their staff often don’t have the capacity to efficiently manage many of the regulatory hurdles in front of them. Their staff may have the capability to clear the hurdles, but the time it takes to come up to speed, learn what to do in a constantly changing regulatory environment, build up appropriate processes, etc. can put them at the back of the pack. And, in the world of regulatory affairs, history does not necessarily repeat itself. A medical device that “cruised through” the FDA 510(k) process several years ago would not necessarily “cruise” to the finish line today.

Balancing Time and Resources

If you are a medical device or IVD manufacturer, Pure Global recommends that you take a careful look at your internal capacity to manage and understand new and ongoing regulatory demands. For example, do you have a full understanding of the clinical data you will need to collect for your EU Post-Market Clinical Follow-up under MDR? Do you have the expertise or manpower to design, set up, run, and analyze results from any required clinical studies like for MDR’s Post-Market Clinical Follow-up? Does your regulatory and engineering staff have the know-how to assess and mitigate current and ongoing cybersecurity risks of your software-based devices?

If you’ve identified gaps in coverage or expertise for any of these items or other critical global regulatory demands, consider going to an outside source to help fill those gaps vs. doing it on your own. Consider using a consulting firm that has a rich set of services, has experience with similar products and challenges to yours that can help answer and deal with these types of questions. Just a few examples include supporting or conducting a single regulatory submission, developing a regulatory strategy for a fleet of products across the globe, or running a part of or all of your regulatory operations as an outsourced consultant.

Feel free to check out our website for more information or contact us to discuss your specific challenges and how Pure Global can help.

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read More

Latest Blog Content

Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.

Blog Article
AI in Medtech Brazil

Artificial intelligence (AI) is revolutionizing the MedTech industry globally and in Brazil, enhancing healthcare delivery and improving patient outcomes through process optimization and data-driven decisions. Responsible AI use, as highlighted by the World Economic Forum, promises life-saving innovations and increased efficiency but requires careful regulatory navigation and transparency. Pure Global's regulatory expertise ensures the swift and successful market introduction of medical technologies in Brazil, fostering innovative healthcare solutions.

Blog Article
Pure Global: Regulatory Decisions for Global Success

Discover how to navigate commercial and regulatory challenges for global success in the medical device industry. Learn strategies for market access, regulatory compliance, and post-market vigilance

Blog Article
New Standards in Medical Device Cybersecurity

Raising cybersecurity standards for medical devices necessitates manufacturers' compliance with new global regulations.

Blog Article
A Strategic Alliance with Pure Global in Brazil

Brazil stands as Latin America's largest medical device market, regulated by ANVISA with recent updates to accommodate new technologies and international harmonization.

Contact us
Request information

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Our closest representative will get back to you within 24 hours.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.